Novo Nordisk A/S (NYSE:NVO)

53.26
Delayed Data
As of Mar 26
 +3.44 / +6.90%
Today’s Change
41.72
Today|||52-Week Range
54.38
+25.85%
Year-to-Date

Stock Price Forecast

The 30 analysts offering 12-month price forecasts for Novo Nordisk have a median target of 50.48, with a high estimate of 63.59 and a low estimate of 39.61. The median estimate represents a -5.21% decrease from the last price of 53.26.

Analyst Recommendations

The current consensus among 31 polled investment analysts is to Buy stock in Novo Nordisk. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.50
Sales
$3.7B
Reporting Date
Apr 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 22.62%
 
 
 
 
 
 
Growthannually 7.41%
 
 
 
 
 
 

Sales

Growthquarterly -7.62%
 
 
 
 
 
 
Growthannually 9.04%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account